Zydus Pharmaceuticals US Inc is recalling from the American market over 3.31 lakh bottles of Divalproex Sodium delayed release tablets used for the treatment of seizures and manic episodes in patients with bipolar disorder, latest Enforcement Report of the US Food and Drug Administration said. The tablets were manufactured by Ahmedabad-based Cadila Healthcare and are being recalled on account of failed dissolution specifications. Shares of Cadila will remain in focus.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.